The Catalan Biotechnology and digital health companies dedicated to biomedicine and digital health captured 59.8 million euros in 2019 in financing rounds, 4.9% more than in 2018, when the investment volume reached 57 million, according to the ranking elaborated by EXPANSIÓN Catalunya.

SOM Biotech is in third place on the list of those companies. In 2019 SOM Biotech closed a financing round of 7 million euros led by a holding company belonging to a European family with a long tradition in the pharmaceutical sector. Find the complete press release here (press release in Spanish).




    I confirm that by completing this form I have used only personal data about myself and that they are true and up-to-date.
    SOM INNOVATION BIOTECH, S.A. is responsible for the processing of my personal data to manage the newsletter service requested through the form, as well as to track the receipt of these through tracking technologies. The Privacy Policy tells me how I can exercise my rights of access, rectification, deletion, limitation, portability and opposition.